4//SEC Filing
Graboyes Marc H 4
Accession 0001127602-11-007737
CIK 0001097264other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:29 PM ET
Size
7.7 KB
Accession
0001127602-11-007737
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Sale
Common Stock
2011-02-23$3.24/sh−3,800$12,318→ 189,253 total - Sale
Common Stock
2011-02-24$3.13/sh−1,410$4,406→ 187,843 total
Footnotes (4)
- [F1]These shares are being sold pursuant to a 10b5-1 plan for Marc H. Graboyes in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 22, 2011.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $3.2401 to $3.2415. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]These shares are being sold pursuant to a 10b5-1 plan for Marc H. Graboyes in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 23, 2011.
- [F4]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $3.12 to $3.1250. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001305811
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:29 PM ET
- Size
- 7.7 KB